Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Premarin Price Increase Highest Among Branded Drugs in Families USA Report

Executive Summary

Wyeth-Ayerst's March Premarin price increase will likely continue the product's run of faster-than-inflation price increases.

You may also be interested in...



Medicare Rx Will Move Towards FSS Pricing Model - Sen. Rockefeller

A Medicare prescription drug benefit will eventually employ a Federal Supply Schedule-style pricing model, Sen. Rockefeller (D-W.Va.) suggested during a June 12 press conference.

Medicare Rx Will Move Towards FSS Pricing Model - Sen. Rockefeller

A Medicare prescription drug benefit will eventually employ a Federal Supply Schedule-style pricing model, Sen. Rockefeller (D-W.Va.) suggested during a June 12 press conference.

Wyeth Premarin Market-Share Rebates Challenged In Duramed Antitrust Suit

Wyeth-Ayerst's Premarin market share-based rebates represent an antitrust violation, Duramed maintained in a lawsuit filed Sept. 5 in Cincinnati federal court.

Related Content

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel